Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial

Background: Many cancer patients who receive chemotherapy experience adverse drug effects. Pharmacogenomics (PGx) has promise to personalize chemotherapy drug dosing to maximize efficacy and safety. Fluoropyrimidines and irinotecan have well-known germline PGx associations. At our institution, we ha...

詳細記述

書誌詳細

主要な著者:	Natalie Reizine, Everett E. Vokes, Ping Liu, Tien M. Truong, Rita Nanda, Gini F. Fleming, Daniel V.T. Catenacci, Alexander T. Pearson, Sandeep Parsad, Keith Danahey, Xander M. R. van Wijk, Kiang-Teck J. Yeo, Mark J. Ratain, Peter H. O’Donnell
フォーマット:	Artigo
言語:	Inglês
出版事項:	SAGE Publishing 2020-12-01
シリーズ:	Therapeutic Advances in Medical Oncology
オンライン･アクセス:	https://doi.org/10.1177/1758835920974118
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!